MedTrace Logo

Observational Study of the Heart Repair Technologies Mitral Bridge in Treating Mitral Valve Regurgitation

NCT03511716 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2020-10-08

No results posted yet for this study

Summary

Prospective, observational, multi-center trial in which patients with mitral regurgitation sufficient to merit mitral valve repair will receive a surgical transvalvular, intra-annular Mitral Bridge™ to reduce or eliminate mitral regurgitation.

Conditions

  • Mitral Regurgitation

Interventions

DEVICE

HRT Mitral Bridge Mitral Valve Repair

Surgical mitral valve implant intended to reduce mitral regurgitation by direct reduction of the septo-lateral mitral annular diameter, promoting early coaptation of the valve leaflets and restraining the leaflets below the intra-annular plane

Sponsors & Collaborators

  • Na Homolce Hospital

    collaborator OTHER

  • Heart Repair Technologies, Inc.

    lead INDUSTRY

Principal Investigators

  • Štěpán ČERNÝ, MD, PhD, MBA · Cardiac Surgeon, Head of Hybrid Operating Room,

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-06
Primary Completion
2019-08-31
Completion
2019-08-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03511716 on ClinicalTrials.gov